QurAlis' CEO and founder Kasper Roet (center stage) giving his presentation earlier today about innovations in #ALS clinical trials at the #TRICALS Master Class being held 2/21-2/23 in Amsterdam. #ALS #FTD #precisionmedicine #neurodegenerativediseases
QurAlis’ Post
More Relevant Posts
-
Hybrid System Spectrum Medical continues to provide new technologies specifically designed to improve performance and therefore improve patient outcomes. The Hybrid Cardiotomy-Venous System is as easy to use as a traditional hard shell system. It primes quickly and familiar Vacuum Assist approaches are easily used. The Hybrid System also provides the inherent safety of a soft bag while minimizing the need for manual air removal techniques. Whether a Team currently uses Mini-bypass, has not yet attempted Mini-bypass, uses a Soft-bag or a Hard-shell reservoir, all will appreciate the easy to use Hybrid System Technologies. The improvements provide: gross venting of venous line air, control of patient volume, options to separately handle vented and suctioned blood, utilization of common Vacuum assist techniques while avoiding the complexity of a kinetic venous assist device, and elimination of the difficulties of converting from a Mini-bypass circuit to full drainage during unpredictable clinical situations. The Hybrid System; developed to successfully address a wide variety of challenging clinical situations.
Recently, I had the beautiful opportunity to try out a new innovation in the field of extracorporeal circulation. Here is a short video in 4x speed (so i hope it's not too boring 😉), showing the function and mode of operation as well as showing how the collapsible and hardshell parts work together. The idea is simple. As long as the filling volume does not exceed 2 liters, the blood in the reservoir has almost no contact with air. The reservoir works excellently. I hope to conduct a larger trial series to investigate the exact characteristics on patients. 🤝❤️ From our hearts, for your hearts! 🤝❤️ #perfusion #cpb #hybrid #future #heartsurgery #heart #lung #machine
To view or add a comment, sign in
-
🗓️ Mark your calendars! Exciting sessions to watch at #TCT2023: Discover fresh insights from Protembis GmbH on cerebral embolic protection in #TAVR. 🫀🧠🛡️ #TAVR #CerebralProtection #MedicalAdvancements
Welcome to #TCT2023. When planning your agenda, we invite you to consider two new data presentations from #Protembis on Wednesday during the 'Stroke and Cerebral Embolic Protection in TAVR' session. This is located in the Emerging Clinical Science & Research area, Hall A, Exhibition Level, Moscone South: Moderated Abstracts Station 1. 10:00 AM: ProtEmbo: A Potential Shield Against Stroke and Cerebral Lesions in TAVR; Illustrated Using DW-MRI to Assess Device Efficacy o Abstract Presenter. Tobias Schmidt MD 10:27 AM: ProtEmbo-C Trial: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR o Abstract Presenter. Stephan Haussig MD #TAVR #TAVI #Protembis Nikos Werner Darren Mylotte #cerebralprotection #CEP
To view or add a comment, sign in
-
📹 🇫🇷 Our research partners, G. Courtine, and Jocelyne Bloch, stopped by BFM Business in Paris, France last week to chat with Laure Closier and Christophe Jakubyszyn on “Good Morning Business” about our plans to commercialize our first product, the investigational ARC-EX® System, in the US later this year. During the nearly ten-minute discussion, the pair also discussed their work using brain-computer interface technology to help a paralyzed man walk more efficiently using the power of thought and about our $20M capital raise in Europe last week. 🎤 ✨Thanks to BFM Business for the thoughtful and informative conversation! We appreciate your time and interest in these important topics, including the unmet challenges of those with spinal cord injuries. *All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use. #EmpoweringMovement #SCI #Innovation
To view or add a comment, sign in
-
No matter the phase of your project, from pilot study to Phase IV post-market study, MERIT provides the expertise and technology to help you achieve your development goals. We seamlessly manage the imaging components of your trial, creating efficiencies for your #drugdevelopment. Check out summaries of two of our #ophthalmology case studies to learn more: https://lnkd.in/dPrVxdHZ #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #casestudy #imagingsolutions
To view or add a comment, sign in
5,883 followers